Last reviewed · How we verify

NCT07112118: multimodal

Multimodal Identification of Depressive Symptoms in the Elderly

Not yet recruiting Last updated 11 August 2025
What this trial tests

trial testing data collection in Depression in 2,000 participants. Not yet recruiting.

Timeline
1 September 2025
Primary endpoint
1 September 2026
30 December 2027

Quick facts

Lead sponsorWuhan Mental Health Centre
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment2,000
Start date1 September 2025
Primary completion1 September 2026
Estimated completion30 December 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Wuhan Mental Health Centre

Who can join

Adults 60 to 100, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Screening with depression scales alone is subjective, and relying on single-modal data often leads to incomplete identification of symptoms that are easily missed or misdiagnosed. In this study, we first aim to use artificial intelligence to construct a depression symptom recognition model, concatenate multimodal features such as facial expression, audio, text, and postural behavior, and deeply fuse them to construct a multimodal model.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of data collection

Trials testing the same drug.

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Wuhan Mental Health Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07112118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing